The abuse of psychomotor stimulants such as cocaine and methamphetamine is a continuing and very serious problem worldwide for which there is no accepted medication. Numerous lines of investigation indicate that elevation of dopamine (DA) in the nucleus accumbens (NAC) is largely responsible for the reinforcing (rewarding) effects of many classes of drugs including cocaine and methamphetamine. Although the precise mechanism of DA elevation in the NAC differs among drug classes, medications that suppress or deplete such elevation of DA may thus be useful in the treatment and prevention of diverse, destructive self-administration behaviors including excessive eating. We have pursued the chemical synthesis and identification of biogenic amine agonists and their antagonists as research tools and potential medications. In one example, we developed a practical nonchromatographic chemical synthesis of the 5-HT2A receptor antagonist MDL100,907 that is enabling numerous studies requiring this critical research tool. We have also studied the discriminative stimulus effects of MDL100,907 and several other drugs in order to gain further insight into their 5-HT receptor subtype(s) selectivity and the possible receptor role in certain neuropsychiatric disorders. In another study, we showed that MDL 100,907 significantly attenuated drug- and cue-induced reinstatement of cocaine but had no significant effects on cocaine self-administration in rhesus macaques. MDL 100,907 attenuated cocaine-induced dopamine overflow in the caudate nucleus but not in the nucleus accumbens as measured by in vivo microdialysis. These data suggest that important abuse-related effects of cocaine are mediated by distinct striatal dopamine projection pathways.

Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
2013
Total Cost
$328,496
Indirect Cost
Name
National Institute on Drug Abuse
Department
Type
DUNS #
City
State
Country
Zip Code
Rosas-Hernandez, Hector; Cuevas, Elvis; Lantz, Susan M et al. (2016) Methamphetamine, 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxypyrovalerone (MDPV) induce differential cytotoxic effects in bovine brain microvessel endothelial cells. Neurosci Lett 629:125-30
Katz, Jonathan L; Hiranita, Takato; Kopajtic, Theresa A et al. (2016) Blockade of Cocaine or σ Receptor Agonist Self Administration by Subtype-Selective σ Receptor Antagonists. J Pharmacol Exp Ther 358:109-24
Hutsell, Blake A; Cheng, Kejun; Rice, Kenner C et al. (2016) Effects of the kappa opioid receptor antagonist nor-binaltorphimine (nor-BNI) on cocaine versus food choice and extended-access cocaine intake in rhesus monkeys. Addict Biol 21:360-73
Serafine, Katherine M; Rice, Kenner C; France, Charles P (2015) Directly Observable Behavioral Effects of Lorcaserin in Rats. J Pharmacol Exp Ther 355:381-5
Anastasio, Noelle C; Stutz, Sonja J; Fink, Latham H L et al. (2015) Serotonin (5-HT) 5-HT2A Receptor (5-HT2AR):5-HT2CR Imbalance in Medial Prefrontal Cortex Associates with Motor Impulsivity. ACS Chem Neurosci 6:1248-58
Fink, Latham H L; Anastasio, Noelle C; Fox, Robert G et al. (2015) Individual Differences in Impulsive Action Reflect Variation in the Cortical Serotonin 5-HT2A Receptor System. Neuropsychopharmacology 40:1957-68
Carbonaro, Theresa M; Eshleman, Amy J; Forster, Michael J et al. (2015) The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice. Psychopharmacology (Berl) 232:275-84
Leitl, Michael D; Onvani, Sara; Bowers, M Scott et al. (2014) Pain-related depression of the mesolimbic dopamine system in rats: expression, blockade by analgesics, and role of endogenous κ-opioids. Neuropsychopharmacology 39:614-24
Kupchik, Yonatan M; Scofield, Michael D; Rice, Kenner C et al. (2014) Cocaine dysregulates opioid gating of GABA neurotransmission in the ventral pallidum. J Neurosci 34:1057-66
Cunningham, Kathryn A; Anastasio, Noelle C; Fox, Robert G et al. (2013) Synergism between a serotonin 5-HT2A receptor (5-HT2AR) antagonist and 5-HT2CR agonist suggests new pharmacotherapeutics for cocaine addiction. ACS Chem Neurosci 4:110-21

Showing the most recent 10 out of 35 publications